Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred
Introduction
Porcine reproductive and respiratory syndrome (PRRS) is an economically significant disease of pigs (Rossow, 1998). The causal agent, PRRS virus (PRRSV), is a small RNA virus of the Arteriviridae family (Cavanagh, 1997). Although, in general, PRRS is clinically similar in North America and Europe, the respective strains differ in virulence (Halbur et al., 1996) and in antigenic (Bautista et al., 1993, Nelson et al., 1993) and genetic (Meng et al., 1995) properties. This heterogeneity is likely to be one of the principal obstacles to effective prevention and control of the disease using commercial vaccines (Meng, 2000).
Pigs naturally infected with PRRSV develop strong homologous immunity preventing re-infection with the same strain (Lager and Mengeling, 1997, Lager et al., 1997, Lager et al., 1999, Nielsen et al., 1997, Mengeling et al., 2003). Protective immunity has also been observed with modified live virus (MLV) and inactivated virus vaccines when the parent virus strain used to produce the vaccine was used for the challenge (Hesse et al., 1996, Gorcyca et al., 1997, Plana-Duran et al., 1997). However, naturally immunized pigs seem to be inconsistently and less completely protected against challenge with heterologous strains (Lager et al., 1999, Mengeling et al., 1999). Similar results have been obtained with gilts immunized with American MLV vaccines and challenged with a heterologous American strain of PRRSV (Gorcyca et al., 1997, Osorio et al., 1998) and with growing pigs immunized with European MLV vaccines and then challenged with a heterologous American strain of PRRSV (van Woensel et al., 1998, Labarque et al., 2003).
These results suggest that the degree of protection afforded by the vaccination of susceptible pigs depends on the degree of similarity between the PRRSV-vaccine strain and the field strain to which the pigs are exposed. Until recently, it was thought that vaccines based on European strains would provide effective protection against any wild-type strain circulating in Europe. However, the discovery of genetic diversity among European strains (Forsberg et al., 2002, Stadejek et al., 2002) and the identification of the three major clusters of field isolates, namely a cluster of Lelystad-like isolates, a cluster of purely Danish isolates, and a cluster of highly diverse Italian-like isolates (Forsberg et al., 2002), highlight the importance of assessing the efficacy of current European-type vaccines based on viruses belonging to the Lelystad-like cluster against the genetically diverse European clusters. Labarque et al. (2004) and Scortti et al. (2006) have shown that the efficacy of European-type MLV vaccines against strains of a different genetic cluster is only partial. Nonetheless, it is assumed that these products would provide good protection against heterologous isolates of the same genomic cluster, based on the genomic similarity between them, with the assumption that viruses that are closely related genetically will be also related antigenically. However, little is known about the correlation between genomic and antigenic properties.
Therefore, the objective of the present study was to determine the degree of protection conferred by a Lelystad-like MLV vaccine against a heterologous wild-type isolate of the same cluster.
Section snippets
Animals and facilities
Fourteen 3-week-old crossbred piglets from a herd free of PRRSV and with no measurable PRRSV serum antibody titres were randomly assigned to groups of four to five animals and housed in isolation in pens with a concrete floor and an automatic watering system. This study was approved by the Animal Ethics Committee of the Complutense University, Madrid (Spain).
Vaccine, virus and cell cultures
The MLV vaccine used (Porcilis® PRRS, Intervet Laboratories) is based on the Lelystad-like cluster of European PRRSV strains. The parent
Clinical signs
No adverse reactions to vaccination were noted and pigs from all experimental groups remained in good health until experimental inoculation with virulent PRRSV. After challenge, moderate clinical signs were observed in the pigs from Groups A and B. Specifically, most pigs from Group A showed a slight increase in rectal temperature from day 3 to day 5 post-inoculation (p.i.). In addition, depression was recorded for pig No. 1 on day 3 p.i. and for pig No. 3 on days 3 and 4 p.i. Finally, pig No.
Discussion
The impact of PRRSV on pig production has stimulated the development of various types of vaccines for controlling disease, both in growing pigs and in breeding females. Decisions on whether to use MLV vaccines to control PRRSV in growing pigs are sometimes based on the degree of ORF-5 homology between a field strain and commercially available vaccines. Therefore, we investigated the ability of one commercially available attenuated PRRSV vaccine, belonging to the Lelystad cluster, to confer
Acknowledgements
This study was supported by grant no. AGL2001-2055 from the Spanish CICYT. Esther Álvarez was supported by a fellowship of the Spanish CICYT.
References (48)
- et al.
The genetic diversity of European type PRRSV is similar to that of the North American type but is geographically skewed within Europe
Virology
(2002) - et al.
Characterization of the carrier state in porcine reproductive and respiratory syndrome virus infection
Veterinary Microbiology
(2002) - et al.
Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines
Veterinary Microbiology
(2003) - et al.
Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy
Vaccine
(2004) - et al.
Duration of homologous porcine reproductive and respiratory syndrome virus immunity in pregnant swine
Veterinary Microbiology
(1997) - et al.
Role of neutralizing antibodies in PRRSV protective immunity
Veterinary Immunology and Immunopathology
(2004) - et al.
Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome
Veterinary Microbiology
(2003) - et al.
Examination of virus shedding in semen from vaccinated and from previously infected boars after experimental challenge with porcine reproductive and respiratory syndrome virus
Veterinary Microbiology
(1997) - et al.
A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions
Vaccine
(2001) - et al.
Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity
Virology
(2002)